Compare 10X Genomics Inc (TXG) vs Viking Holdings Ltd Ordinary Shares (VIK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Viking Holdings Ltd Ordinary Shares — how do they compare? 10X Genomics Inc trades at $79.1 (market cap $10.07B), while Viking Holdings Ltd Ordinary Shares trades at $81.62 (market cap $36.46B). The key difference: Viking Holdings Ltd Ordinary Shares is far larger — about 3.6× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Viking Holdings Ltd Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold 10X Genomics Inc for 92 Days and Viking Holdings Ltd Ordinary Shares for 0 Days on average.
| TXG | VIK | |
|---|---|---|
Market Cap | $10.07B | $36.46B |
Volume | 5,657,286 | 3,461,906 |
Sector | Health | Consumer Cyclical |
52-Week High | $97.74 | $108.26 |
52-Week Low | $11.48 | $57.08 |
Typical Hold Time | 92 Days | 0 Days |
Enterprise Value | $9.59B | $38.84B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
10x Genomics (TXG) trades at $76.10, down 5.65% on the day, as technical indicators signal bearish momentum with the stock below key resistance levels. The company shows improving fundamentals with three consecutive quarterly earnings beats and positive operating cash flow of $136M in 2025, though it remains unprofitable with a -12.18% net margin. Recent developments include the launch of Atera spatial biology platform shipments and a patent victory against Parse Biosciences.
TXG presents a mixed investment case with strong product innovation and improving financial trends offset by high valuation metrics and persistent losses. The stock's risk/reward appears balanced near analyst consensus targets, requiring successful execution on Atera commercialization and path to profitability to justify current multiples.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Viking Holdings Ltd Ordinary Shares
Viking operates river, ocean, and expedition cruises. Its itineraries focus on destination-based travel across Europe, the Americas, and other regions.
Read more on VIK →
